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ABSTRACT	  
Triple	  negative	  breast	  cancer	  (TNBC)	  is	  a	  subtype	  that	  lacks	  expression	  of	  progesterone	  
and	  estrogen	  receptors,	  and	  does	  not	  over-­‐express	  human	  epidermal	  growth	  factor	  receptor	  2	  
(HER2).	  TNBC	  is	  not	  responsive	  to	  standard	  therapies	  that	  target	  these	  receptors	  and	  is	  
associated	  with	  poor	  prognosis,	  a	  high	  rate	  of	  recurrence,	  and	  aggressive	  metastasis.	  The	  
purpose	  of	  this	  study	  was	  to	  characterize	  the	  bone	  marrow	  microenvironment	  during	  the	  
process	  of	  primary	  tumor	  growth	  and	  metastasis	  in	  murine	  TNBC	  models.	  We	  hypothesize	  that	  
the	  expression	  of	  the	  inflammatory	  chemokines	  KC/CXCL1	  and	  MCP-­‐1/CCL2	  in	  the	  bone	  marrow	  
microenvironment	  promotes	  the	  development	  of	  breast	  cancer	  metastasis.	  The	  2225LM	  murine	  
tumor	  has	  gene	  expression	  patterns	  comparable	  to	  human	  tumors	  of	  the	  basal-­‐like	  TNBC	  
phenotype	  and	  the	  T11	  murine	  tumor	  mirrors	  the	  claudin-­‐low	  TNBC	  phenotype.	  In	  our	  studies,	  
tumors	  (1-­‐2	  mm)	  are	  implanted	  in	  either	  the	  subcutaneous	  flank	  or	  the	  mammary	  fat	  pad	  of	  
syngeneic,	  female	  mice	  and	  are	  excised	  ~2	  weeks	  later	  to	  reliably	  generate	  growth	  of	  seeded	  
metastases.	  Previous	  data	  from	  our	  laboratory	  found	  significantly	  increased	  levels	  of	  KC/CXCL1	  
and	  MCP-­‐1/CCL2	  in	  primary	  tumors	  of	  both	  tumor	  lines	  compared	  to	  tissue	  from	  naïve	  mice.	  In	  
the	  present	  study,	  bone	  marrow	  is	  flushed	  from	  femurs	  and	  tibias	  of	  tumor-­‐implanted	  mice,	  
separated	  into	  cellular	  and	  soluble	  components	  and	  assayed	  by	  ELISA.	  MCP-­‐1	  is	  significantly	  
elevated	  in	  the	  extracellular	  component	  of	  bone	  marrow	  of	  T11-­‐implanted	  mice.	  KC/CXCL1	  is	  
not	  significantly	  elevated	  in	  either	  the	  extracellular	  or	  intracellular	  bone	  marrow	  of	  T11-­‐
implanted	  mice.	  KC/CXCL1	  is	  expressed	  by	  inflammatory	  cells	  and	  osteoblasts	  and	  is	  a	  
chemoattractant	  for	  inflammatory	  cells	  and	  certain	  tumor	  cells.	  MCP-­‐1/CCL2	  is	  expressed	  by	  a	  
variety	  of	  inflammatory	  cells	  and	  myeloid	  progenitor	  cells	  and	  is	  a	  chemoattractant	  for	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monocytes/macrophages.	  Our	  results	  are	  consistent	  with	  the	  premise	  that	  an	  increase	  in	  MCP-­‐
1/CCL2	  in	  the	  bone	  marrow	  promotes	  the	  development	  of	  claudin-­‐low	  breast	  cancer	  lung	  
metastasis.	  	  
INTRODUCTION	  
Metastasis	  requires	  that	  a	  tumor	  cell	  is	  able	  to	  dissociate	  from	  the	  primary	  tumor,	  enter	  
circulation	  or	  the	  lymphatics,	  invade	  another	  tissue,	  and	  grow	  in	  a	  new	  environment	  (Joyce,	  
2008).	  Investigations	  into	  the	  patterns	  of	  metastases	  have	  resulted	  in	  the	  discovery	  of	  cellular	  
and	  molecular	  changes	  in	  tissues	  prior	  to	  the	  infiltration	  of	  a	  tumor	  cell.	  Research	  in	  the	  last	  
decade	  has	  deemed	  these	  changes	  in	  the	  molecular	  and	  cellular	  composition	  of	  tissues,	  the	  
formation	  of	  a	  “pre-­‐metastatic	  niche”.	  A	  pre-­‐metastatic	  niche	  is	  the	  tissue	  microenvironment	  
that	  supports	  tumor	  cell	  attraction,	  retention,	  and	  growth	  (Kaplan,	  2006).	  The	  
microenvironment	  attracts	  and	  supports	  the	  tumor	  cell(s)	  by	  the	  changes	  in	  soluble	  mediators,	  
molecules	  involved	  in	  the	  communication	  between	  cells	  of	  the	  immune	  system,	  and	  altering	  
the	  presence	  of	  cell	  populations	  involved	  in	  immune	  response.	  
Research	  studies	  suggest	  that	  cells	  involved	  in	  the	  alteration	  of	  tissue	  into	  a	  pro-­‐tumor	  
microenvironment	  are	  cells	  of	  the	  immune	  system,	  which	  normally	  function	  to	  defend	  the	  body	  
from	  pathogens	  and	  maintain	  homeostasis.	  Cells	  of	  the	  immune	  system	  are	  produced	  in	  the	  
bone	  marrow	  by	  the	  process	  of	  hematopoiesis.	  Hematopoiesis	  is	  the	  process	  in	  which	  
hematopoietic	  stem	  cells	  in	  the	  bone	  marrow	  differentiate	  and	  mature	  into	  lymphocytes	  and	  
myeloid	  cells	  based	  on	  chemical	  signals.	  These	  myeloid	  cells	  have	  been	  shown	  to	  play	  key	  roles	  
in	  cancer-­‐related	  inflammation	  and	  are	  the	  focus	  of	  this	  project.	  Inflammation	  is	  thought	  to	  be	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a	  major	  contributor	  to	  the	  tumor	  microenvironment,	  as	  it	  has	  the	  ability	  to	  promote	  tumor	  cell	  
insurgence	  and	  sustain	  tumor	  growth	  (Caronni,	  2014).	  	  
Bone	  marrow-­‐derived	  myeloid	  cells	  that	  have	  been	  shown	  to	  play	  a	  significant	  role	  in	  
this	  inflammatory	  pre-­‐metastatic	  niche	  include	  monocytes,	  macrophages	  and	  neutrophils	  
(Caronni,	  2014).	  Monocytes,	  macrophages,	  and	  neutrophils	  are	  derived	  from	  the	  same	  bone	  
marrow	  precursor	  cell.	  The	  differentiation	  and	  maturation	  of	  these	  cells	  depend	  on	  chemical	  
signals	  present	  in	  the	  bone	  marrow	  at	  the	  time	  of	  production.	  
	  Monocytes	  are	  cells	  that	  circulate	  in	  the	  bone	  marrow,	  blood,	  and	  spleen	  and	  have	  the	  
ability	  to	  produce	  inflammatory	  chemical	  signals	  and	  phagocytose	  cells	  and	  toxic	  molecules.	  
Macrophages	  are	  phagocytic	  cells	  that	  reside	  in	  tissues	  and	  are	  known	  to	  play	  a	  role	  in	  tissue	  
homeostasis.	  They	  are	  able	  to	  recognize	  pathogens	  and	  induce	  production	  of	  inflammatory	  
cytokines	  (Geissman,	  2010).	  	  
	  Neutrophils	  are	  cells	  that	  are	  typically	  the	  first	  leukocytes	  to	  localize	  to	  a	  site	  of	  
inflammation.	  They	  are	  able	  to	  eliminate	  pathogens	  via	  both	  intra	  and	  extracellular	  
mechanisms	  including	  phagocytosis	  and	  the	  formation	  of	  extracellular	  traps.	  Distinctive	  
features	  of	  neutrophils	  include	  a	  polymorphic	  nucleus	  and	  the	  ability	  to	  release	  granules	  that	  
use	  anti-­‐microbial	  molecules	  and	  proteases	  to	  kill	  pathogens.	  Neutrophils	  are	  released	  from	  the	  
bone	  marrow	  in	  a	  mature	  state	  whereas	  macrophages	  are	  released	  from	  the	  bone	  marrow	  as	  
monocytes	  and	  mature	  into	  macrophages	  once	  they	  begin	  to	  reside	  in	  certain	  tissues	  
(Kolaczkowska,	  2013).	  However,	  not	  all	  monocytes	  released	  from	  the	  bone	  marrow	  mature	  into	  
macrophages.	  Monocytes	  that	  continue	  in	  the	  body’s	  circulation	  avoid	  maturation	  into	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macrophages.	  Evidence	  suggests	  that	  once	  an	  immune	  cell	  arrives	  in	  tissue,	  tumor	  cells	  can	  
modify	  inflammatory	  cell	  types	  to	  alter	  them	  into	  tumor	  promoting	  rather	  than	  tumor	  
suppressive	  (Joyce,	  2008).	  For	  macrophages,	  investigations	  have	  indicated	  that	  these	  cells	  can	  
switch	  from	  a	  tumor	  suppressive	  M1	  phenotype	  to	  a	  pro-­‐tumor	  M2	  phenotype.	  Neutrophils	  
follow	  the	  same	  trend;	  N1	  neutrophils	  are	  thought	  to	  be	  anti-­‐tumor	  and	  N2	  neutrophils	  are	  
thought	  to	  be	  pro-­‐tumor.	  
Osteoblasts	  are	  cells	  that	  originate	  from	  mesenchymal	  stem	  cells	  in	  the	  bone	  marrow	  
and	  are	  responsible	  for	  bone	  formation	  and	  remodeling.	  Recent	  studies	  suggest	  that	  
osteoblasts	  increase	  expression	  of	  inflammatory	  cytokines	  in	  the	  presence	  of	  cancer	  cells	  
(Bussard,	  2010).	  Cancer	  cells	  in	  the	  bone	  marrow	  have	  also	  been	  shown	  to	  promote	  
osteoclastogenesis	  and	  bone	  resorption	  (Chen,	  2010).	  	  
	  Inflammation	  that	  is	  produced	  by	  the	  immune	  system	  because	  of	  wound	  healing	  is	  
usually	  self-­‐limiting.	  However,	  when	  the	  inflammation	  is	  not	  self-­‐limiting,	  it	  creates	  a	  prime	  
environment	  for	  cell	  proliferation.	  Observing	  an	  increase	  in	  the	  production	  of	  these	  
macrophage	  and	  neutrophil	  cell	  populations	  in	  the	  bone	  marrow	  can	  indicate	  that	  an	  immune	  
response	  is	  taking	  place.	  	  Enhanced	  myeloid	  cell	  production	  from	  the	  bone	  marrow	  during	  an	  
infection	  is	  expected;	  however,	  during	  certain	  inflammatory	  conditions,	  hematopoietic	  stem	  
progenitor	  cells	  are	  thought	  to	  respond	  to	  stimuli	  and	  proliferate	  to	  replenish	  immune	  cells	  
(Baldridge,	  2011).	  An	  enhanced	  amount	  of	  signals	  that	  stimulate	  myeloid	  cell	  production	  in	  the	  
bone	  marrow	  may	  indicate	  infection	  or	  inflammation	  elsewhere.	  The	  same	  chemical	  signals	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that	  stimulate	  the	  bone	  marrow	  during	  inflammation	  are	  expected	  during	  the	  formation	  of	  an	  
inflammatory	  pre-­‐metastatic	  niche.	  
	   Chemical	  signals	  of	  interest	  in	  the	  bone	  marrow	  that	  stimulate	  the	  production	  of	  
myeloid	  cells	  include	  MCP-­‐1	  and	  KC.	  Monocyte	  Chemoattractant	  Protein	  MCP-­‐1/CCL2	  is	  
produced	  by	  a	  variety	  of	  cell	  types	  including	  macrophages	  and	  fibroblasts.	  	  This	  chemokine	  has	  
been	  shown	  to	  promote	  migration	  of	  inflammatory	  monocytes	  from	  the	  bone	  marrow	  into	  the	  
circulation	  (Yadav,	  2010).	  Keratinocyte	  chemoattractant,	  or	  KC/CXCL1	  is	  expressed	  by	  
inflammatory	  cells	  and	  osteoblasts	  and	  is	  a	  chemoattractant	  for	  inflammatory	  cells	  and	  certain	  
tumor	  cells.	  	  Previous	  data	  from	  our	  laboratory	  found	  increased	  levels	  of	  KC/CXCL1	  and	  MCP-­‐
1/CCL2	  in	  primary	  tumors	  and	  in	  lungs	  with	  visible	  metastases	  of	  both	  tumor	  lines,	  compared	  to	  
tissue	  from	  naïve	  mice.	  	  
	  
	   FIGURE	  1:	  Bone	  Marrow	  Microenvironment.	  KC/CXCL1	  and	  MCP-­‐1/CCL2	  may	  influence	  the	  bone	  marrow	  to	  
promote	  bone	  remodeling	  and	  cancer	  cell	  colonization.	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Despite	  a	  common	  tissue	  of	  origin,	  subtypes	  of	  breast	  cancers	  are	  quite	  diverse.	  Triple	  
negative	  breast	  cancer	  (TNBC)	  is	  a	  subtype	  unique	  in	  that	  its	  tumors	  lack	  the	  expression	  of	  
progesterone	  and	  estrogen	  receptors,	  and	  do	  not	  over-­‐express	  human	  epidermal	  growth	  factor	  
receptor	  2	  (HER2)	  (Foulkes,	  2010).	  Because	  of	  this,	  treatment	  of	  Triple	  Negative	  Breast	  Cancer	  
is	  not	  responsive	  to	  standard	  therapies,	  which	  target	  these	  receptors.	  This	  subtype	  of	  breast	  
cancer	  accounts	  for	  15-­‐20%	  of	  all	  breast	  cancers	  and	  is	  associated	  with	  poor	  clinical	  prognosis,	  
high	  rate	  of	  recurrence,	  and	  aggressive	  metastasis	  (Chiorean,	  2013).	  	  	  
The	  purpose	  of	  this	  study	  was	  to	  characterize	  the	  bone	  marrow	  microenvironment	  
during	  the	  process	  of	  primary	  tumor	  growth	  and	  metastasis	  in	  murine	  TNBC	  models.	  We	  
hypothesize	  that	  the	  expression	  of	  the	  inflammatory	  chemokines	  KC/CXCL1	  and	  MCP-­‐1/CCL2	  at	  
metastatic	  sites	  promotes	  the	  development	  of	  breast	  cancer	  metastasis.	  
MATERIALS	  AND	  METHODS	  
Mice:	  Syngenic	  Balb/c	  female	  mice	  were	  obtained	  from	  Charles	  River	  Laboratories	  and	  were	  
housed	  and	  handled	  in	  accordance	  with	  IACUC	  regulations.	  	  
Tumor	  Implantation:	  T11	  and	  2225LM	  tumors	  were	  obtained	  from	  Dr.	  Jason	  Herschkowitz,	  
University	  at	  Albany,	  SUNY.	  Tumor	  sections	  (1-­‐2mm)	  were	  implanted	  in	  either	  the	  
subcutaneous	  flank	  or	  the	  mammary	  fat	  pad	  of	  mice.	  The	  tumors	  were	  then	  excised	  
approximately	  14	  days	  after	  implantation.	  The	  mice	  were	  euthanized	  approximately	  30	  days	  
post	  tumor	  resection.	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Bone	  Marrow	  Isolation:	  The	  tibias	  and	  femurs	  of	  the	  mice	  were	  harvested.	  The	  epiphyses	  were	  
separated	  from	  the	  diaphyses	  of	  the	  bones	  and	  0.5-­‐1.0	  mL	  media	  was	  used	  to	  flush	  the	  
diaphyses.	  The	  epiphyses	  were	  manually	  chopped	  with	  scissors	  and	  added	  to	  the	  flushed	  
media.	  The	  flush	  was	  filtered	  through	  a	  70-­‐micron	  filter.	  The	  flush	  was	  centrifuged	  for	  10	  
minutes	  at	  10	  °C	  at	  1000	  rpm.	  The	  supernatant	  was	  then	  extracted.	  The	  erythrocytes	  in	  the	  cell	  
pellet	  were	  lysed	  using	  a	  Terry	  Fox	  lysis	  buffer	  and	  then	  resuspended	  in	  Iscove’s	  Modified	  
Dulbecco’s	  Medium	  (Gibco,	  Catalog	  number:	  21056023).	  A	  cell	  count	  by	  hemocytometer	  was	  






Chemokine	  Analyses:	  Chemokines	  were	  quantified	  in	  both	  the	  supernatant	  and	  the	  cell	  lysate	  
using	  MCP-­‐1/CCL2	  and	  KC/CXCL1	  sandwich	  ELISAs	  (R&D	  Systems)	  following	  R&D	  Systems	  
recommended	  protocols.	  Chemokine	  levels	  were	  analyzed	  from	  three	  groups	  of	  mice,	  naïve	  
(n=8),	  T11-­‐implanted	  (n=16),	  and	  2225LM-­‐implanted	  (n=16).	  	  
Statistical	  Analysis:	  For	  comparison	  of	  two	  groups,	  we	  used	  an	  unpaired,	  nonparametric,	  two-­‐
tailed	  Mann-­‐Whitney	  t-­‐test	  with	  a	  confidence	  interval	  of	  95	  percent.	  	  
FIGURE	  2:	  Experimental	  Model	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RESULTS	  	  
The	  chemokine	  levels	  in	  each	  group	  of	  mice	  were	  compared	  using	  a	  Mann-­‐Whitney	  T-­‐
test.	  MCP-­‐1/CCL2	  levels	  in	  the	  extracellular	  component	  of	  bone	  marrow	  of	  T11-­‐implanted	  mice	  
were	  significantly	  elevated	  (p=0.004)	  compared	  to	  the	  MCP-­‐1/CCL2	  levels	  in	  the	  naïve	  group	  
(Figure	  3A).	  However,	  KC/CXCL1	  was	  not	  significantly	  elevated	  in	  the	  extracellular	  component	  
of	  the	  bone	  marrow	  of	  T11	  or	  2225LM-­‐implanted	  mice	  compared	  to	  the	  naïve	  group	  (Figure	  
3B).	  We	  also	  analyzed	  the	  KC/CXCL1	  levels	  in	  the	  intracellular	  component	  of	  the	  bone	  marrow	  
(cell	  lysate)	  and	  found	  that,	  although	  KC/CXCL1	  was	  elevated	  in	  the	  T11-­‐implanted	  mice	  
compared	  to	  the	  naïve	  mice,	  the	  increase	  was	  not	  statistically	  significant.	  (Figure	  5).	  Chemokine	  
levels	  were	  not	  significantly	  affected	  by	  the	  location	  of	  tumor	  implantation	  (subcutaneous	  
heteropic	  vs.	  orthotopic	  in	  the	  mammary	  fat	  pad,	  data	  not	  shown).	  Chemokine	  levels	  were	  also	  
compared	  to	  the	  incidence	  of	  visible	  lung	  metastases.	  The	  data	  did	  not	  show	  a	  significant	  
association	  between	  MCP-­‐1/CCL2	  and	  the	  incidence	  lung	  macrometastases	  (Figure	  4A).	  There	  
was	  also	  no	  significant	  association	  between	  KC/CXCL1	  levels	  and	  the	  incidence	  of	  lung	  
























FIGURE	  3:	  Levels	  of	  Extracellular	  Chemokines	  in	  Bone	  Marrow	  A.	  MCP-­‐1/CCL2	  was	  significantly	  elevated	  in	  the	  
T-­‐11	  implanted	  mice	  compared	  to	  the	  naïve	  mice	  (p=0.004).	  B.	  KC/CXCL1	  was	  not	  significantly	  different	  in	  the	  
T11	  and	  2225LM-­‐implanted	  mice	  compared	  to	  the	  naïve	  mice.	  	  
A.	  MCP-­‐1	   	   	   	   	   	   	   B.	  KC	  
FIGURE	  4:	  Bone	  Marrow	  Extracellular	  Chemokine	  Levels	  and	  Incidence	  of	  Lung	  Metastases	  A.	  MCP-­‐1/CCL2	  was	  
elevated	  in	  T11-­‐implanted	  mice	  with	  visible	  lung	  metastases	  (p=0.06).	  B.	  KC/CXCL	  was	  not	  significantly	  changed	  
in	  T11-­‐implanted	  mice	  with	  visible	  lung	  metastases.	  	  
A.	  MCP-­‐1	   	   	   	   	   	   	   B.	  KC	  




During	  this	  study	  we	  sought	  to	  characterize	  the	  chemokine	  levels	  of	  the	  bone	  marrow	  
during	  primary	  tumor	  growth	  and	  metastasis.	  Because	  of	  their	  role	  in	  metastasis	  to	  the	  lungs,	  
we	  chose	  to	  investigate	  MCP-­‐1	  and	  KC	  in	  both	  the	  intracellular	  and	  extracellular	  components	  of	  
the	  bone	  marrow.	  These	  molecules	  may	  influence	  the	  bone	  marrow	  to	  promote	  bone	  
remodeling	  and	  cancer	  cell	  colonization.	  We	  expected	  levels	  of	  these	  chemokines	  in	  the	  bone	  
marrow	  microenvironment	  to	  be	  elevated	  in	  tumor-­‐implanted	  mice	  compared	  to	  naïve	  mice.	  	  
However,	  2225LM-­‐implanted	  mice	  did	  not	  show	  significantly	  elevated	  levels	  of	  either	  
chemokine.	  We	  have	  shown	  that	  secretory	  MCP-­‐1/CCL2	  is	  elevated	  in	  T11-­‐implanted	  mice.	  This	  
finding	  supports	  the	  idea	  of	  chemokine	  changes	  in	  the	  bone	  marrow	  microenvironment	  during	  
the	  processes	  of	  primary	  tumor	  growth	  and	  metastasis.	  Similar	  increases	  in	  bone	  marrow	  levels	  
of	  MCP-­‐1/CCL2	  have	  been	  reported	  via	  cytokine	  analysis	  of	  bone	  culture	  supernatants	  
(Sosnoski,	  2012).	  	  
FIGURE	  5:	  	  Levels	  of	  intracellular	  KC	  in	  Bone	  Marrow.	  KC/CXCL1	  was	  not	  significantly	  elevated	  in	  the	  T11-­‐
implanted	  mice	  compared	  to	  the	  naïve	  mice	  (p=0.08).	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Future	  studies	  will	  inhibit	  MCP-­‐1	  to	  investigate	  its	  role	  in	  metastatic	  progression	  and	  
further	  characterize	  the	  cytokine	  profile	  in	  the	  bone	  marrow.	  	  Possible	  cytokines	  of	  interest	  
may	  include	  G-­‐CSF	  and	  CXCL12,	  which	  have	  been	  shown	  to	  play	  a	  role	  in	  neutrophil	  migration	  
from	  the	  bone	  marrow	  (Christopher,	  2009).	  We	  will	  also	  investigate	  levels	  of	  intracellular	  MCP-­‐
1	  as	  well	  as	  the	  source	  of	  MCP-­‐1	  in	  the	  bone	  marrow	  of	  T11	  implanted	  mice.	  Possible	  sources	  of	  
MCP-­‐1	  include	  T11	  tumor	  cells	  and	  myeloid	  progenitor	  cells	  in	  the	  bone	  marrow.	  An	  increase	  in	  
the	  production	  of	  myeloid	  progenitor	  cells	  in	  the	  bone	  marrow	  may	  indicate	  an	  inflammatory	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